Reducing Addiction Risk in High Schools Through Better Prevention Infrastructure
Official title: Reducing Addiction through Prevention Infrastructure Development (RAPID)
Funded at Washington University · NIH-11582595 · Data updated 2026-11-12
Aims to build a sustainable, school-based system to prevent opioid and other drug use among high school students, especially those at higher risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 1, 2025 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $461,987 |
| NIH project number | 7R61DA063683-02 |
| Project ID | NIH-11582595 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adolescents in high school settings, particularly marginalized youth at higher risk for substance use.
✕Less likely to help
Students in schools or settings without access to prevention infrastructure may not directly benefit.
What this research studies
This grant focuses on creating and refining a multi-tier prevention infrastructure in high schools to help adolescents avoid substance use problems before they start. It uses a phased plan that combines real-world learning with research methods to adapt proven prevention programs for universal, selective, and indicated youth groups. The project partners with schools and communities to ensure long-term, scalable delivery of evidence-based prevention services. The work builds on previous rapid adaptation efforts and uses implementation science to guide rollout and sustainability.
Why it matters
Potential benefit: If successful, it could reduce youth substance use and related costs by enabling schools to deliver lasting prevention programs.
How similar studies have gone: Previous rapid adaptation work shows promise in translating prevention programs to real-world school settings.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Eisman, Andria B — Washington University
- Study coordinator: Eisman, Andria B
Related research
Other NIH-funded projects on the same topics.
-
HEAL Data Platform to share addiction-related data across programs
A platform project to make HEAL data from many programs easier to find and use, helping researchers and clinicians access information about addiction in children and youth.
-
Cognitively-enhanced tDCS to reduce cocaine craving
A study to test whether real brain stimulation together with learning strategies can lessen craving in people with cocaine use disorder.
-
Yale center researching how tobacco products affect use and addiction in people
A Yale research center is studying how nicotine, flavor additives, and other ingredients in tobacco products influence people’s likelihood of starting and becoming addicted.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
Integrating long-acting PrEP into street medicine for people who use drugs
This project tests whether a long-acting HIV prevention shot (lenacapavir) can be feasibly and acceptably offered by street-based health teams to people who use drugs.
-
New statistical methods to study brain networks in substance use and addiction
A small, focused project will develop and test new brain-imaging analysis methods to identify biomarkers linked to substance use risk and addiction, using resting-state MRI data from people with autistic disorder.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.